Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 21,183,000 | 26,865,000 | 12,889,000 | 11,355,000 | 10,983,000 |
Marketable Securities | 7,322,000 | 5,443,000 | 9,392,000 | 22,724,000 | 21,585,000 |
Receivables | 16,777,000 | 16,350,000 | 14,039,000 | 15,890,000 | 16,139,000 |
Inventories | 12,888,000 | 12,809,000 | 10,268,000 | 11,675,000 | 11,437,000 |
Other current assets | 0 | 0 | 5,830,000 | 0 | 0 |
TOTAL | $60,567,000 | $64,388,000 | $55,294,000 | $65,236,000 | $63,847,000 |
Non-Current Assets | |||||
PPE Net | 20,576,000 | 20,174,000 | 17,982,000 | 18,152,000 | 18,354,000 |
Intangibles | 91,686,000 | 93,023,000 | 74,536,000 | 73,719,000 | 76,574,000 |
Other Non-Current Assets | 18,857,000 | 18,384,000 | 39,566,000 | 18,017,000 | 18,949,000 |
TOTAL | $131,119,000 | $131,581,000 | $132,084,000 | $109,888,000 | $113,877,000 |
Total Assets | $191,686,000 | $195,969,000 | $187,378,000 | $175,124,000 | $177,724,000 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 10,443,000 | 9,909,000 | 9,889,000 | 10,153,000 | 9,765,000 |
Accrued Expenses | 29,339,000 | 28,219,000 | 27,347,000 | 28,980,000 | 28,771,000 |
TOTAL | $54,170,000 | $60,373,000 | $55,802,000 | $45,543,000 | $44,821,000 |
Non-Current Liabilities | |||||
Long Term Debt | 33,901,000 | 34,928,000 | 26,886,000 | 27,603,000 | 28,292,000 |
aiOther Non-Current Liabilities | 23,579,000 | 25,382,000 | 23,895,000 | 22,433,000 | 23,239,000 |
TOTAL | $61,107,000 | $64,727,000 | $54,772,000 | $54,982,000 | $56,546,000 |
Total Liabilities | $115,277,000 | $125,100,000 | $110,574,000 | $100,525,000 | $101,367,000 |
Shareholders' Equity | |||||
Shares Outstanding, K | 2,598,970 | 2,598,734 | 2,604,286 | 2,614,484 | 2,629,180 |
Common Shares | 3,120,000 | 3,120,000 | 3,120,000 | 3,120,000 | 3,120,000 |
Retained earnings | 129,381,000 | 124,558,000 | 128,345,000 | 127,917,000 | 126,216,000 |
Other shareholders' equity | -11,875,000 | -12,626,000 | -12,967,000 | -15,292,000 | -13,843,000 |
TOTAL | $76,409,000 | $70,869,000 | $76,804,000 | $74,599,000 | $76,357,000 |
Total Liabilities And Equity | $191,686,000 | $195,969,000 | $187,378,000 | $175,124,000 | $177,724,000 |